Table 4 Postoperative laboratory data
Group L | Group N | Group H | Number | |
|---|---|---|---|---|
N = 499 | N = 3,064 | N = 914 | ||
Lactate, mg/dL | * | |||
0–6 hours | 15.0 (10.0-21.0) | 15.0 (10.0-22.0) | 22.0* (12.0-50.8) | 4,188 |
6–12 hours | 14.0 (10.0-20.0) | 14.0 (10.0-21.0) | 16.0* (10.0-26.0) | 4,254 |
12–18 hours | 11.0 (9.00-15.0) | 11.0 (9.00-16.0) | 12.0* (9.00-17.0) | 4,274 |
18–24 hours | 12.0 (9.00-16.0) | 12.0 (9.00-16.0) | 12.0 (9.00-16.0) | 4,335 |
Blood glucose, mg/dL | * | |||
0–6 hours | 142* (123–164) | 148 (129–169) | 152* (126–184) | 4,188 |
6–12 hours | 132* (117–149) | 135 (119–153) | 137* (119–158) | 4,254 |
12–18 hours | 128 (112–146) | 131 (116–146) | 129 (112–148) | 4,254 |
18–24 hours | 136 (118–156) | 137 (120–157) | 135 (118–158) | 4,335 |
Haemoglobin, g/dL | * | |||
POD 0 | 10.0* (9.30-10.8) | 10.3 (9.50-11.1) | 10.3 (9.50-11.3) | 4,350 |
POD 1 | 9.70 (9.10-10.4) | 9.70 (9.00-10.5) | 9.80 (9.10-10.6) | 4,477 |
POD 2 | 9.60 (9.10-10.4) | 9.70 (9.00-10.4) | 9.70 (9.10-10.4) | 4,477 |
POD 3 | 9.70 (9.20-10.5) | 9.80 (9.20-10.6) | 9.80 (9.20-10.6) | 4,477 |
Leukocytes, /nL | * | |||
POD 0 | 12.0 (9.48-15.4) | 12.4 (9.75-15.5) | 13.2* (10.1-16.8) | 4,171 |
POD 1 | 13.1 (10.7-16.6) | 13.8 (11.0-16.7) | 14.4* (11.3-17.8) | 4,413 |
POD 2 | 13.6 (11.0-16.9) | 14.0 (11.2-17.1) | 14.9* (11.6-18.6) | 4,439 |
POD 3 | 11.9 (9.27-15.0) | 11.6 (9.36-14.4) | 12.0* (9.50-15.6) | 4,446 |
Procalcitonin, μg/L | * | |||
POD 0 | 0.48 (0.48-0.49) | 0.58 (0.14-1.41) | 1.70 (0.27-5.87) | 22 |
POD 1 | 1.63 (0.39-3.98) | 1.80 (0.56-5.28) | 4.19* (1.62-11.8) | 194 |
POD 2 | 1.06 (0.34-4.90) | 1.52 (0.40-5.45) | 4.37* (1.50-11.9) | 562 |
POD 3 | 1.00 (0.34-3.27) | 0.90 (0.30-3.57) | 3.05* (0.80-8.45) | 979 |
Alanine transaminase, U/L | * | |||
POD 0 | 22.0 (16.0-31.0) | 22.0 (16.0-33.0) | 23.0 (16.0-35.0) | 3,999 |
POD 1 | 24.0 (17.0-35.0) | 23.0 (17.0-35.0) | 24.0 (17.0-38.0) | 4,336 |
POD 2 | 24.0 (18.0-38.0) | 24.0 (17.0-35.0) | 25.0* (18.0-39.0) | 4,389 |
POD 3 | 25.5 (18.0-39.0) | 24.0 (17.0-36.0) | 25.0 (18.0-40.0) | 4,401 |
Creatinine, mg/dL | * | * | ||
Last preop | 1.02* (0.86-1.20) | 0.98 (0.83-1.18) | 1.08* (0.88-1.35) | 4,322 |
POD 1 | 1.14* (0.91-1.52) | 1.06 (0.86-1.37) | 1.19* (0.93-1.73) | 4,412 |
POD 2 | 1.15* (0.90-1.55) | 1.04 (0.82-1.42) | 1.20* (0.90-1.77) | 4,442 |
POD 3 | 1.11* (0.85-1.48) | 1.00 (0.80-1.37) | 1.16* (0.86-1.70) | 4,449 |
International normalized ratio | * | * | ||
POD 0 | 1.31 (1.22-1.43) | 1.30 (1.22-1.40) | 1.33* (1.23-1.45) | 4,153 |
POD 1 | 1.27 (1.19-1.37) | 1.26 (1.18-1.35) | 1.28* (1.20-1.39) | 4,412 |
POD 2 | 1.26* (1.19-1.37) | 1.25 (1.18-1.35) | 1.27* (1.19-1.39) | 4,437 |
POD 3 | 1.24* (1.15-1.34) | 1.21 (1.13-1.31) | 1.23* (1.14-1.35) | 4,445 |
Creatine kinase MB, U/L | * | * | ||
POD 0 | 38.0* (27.0-55.5) | 34.0 (26.0-52.0) | 38.0* (26.0-61.0) | 3,913 |
POD 1 | 33.0* (22.0-56.0) | 31.0 (22.0-51.0) | 33.0* (22.0-58.0) | 4,191 |
POD 2 | 27.0* (19.0-46.0) | 24.0 (17.0-39.0) | 25.0 (17.0-43.0) | 4,222 |
POD 3 | 23.5* (16.0-38.0) | 21.0 (15.0-33.0) | 21.0 (15.0-35.0) | 4,233 |